Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

10-02-2015 | Pregnancy | Review | Article

Stillbirth in the Pregnancy Complicated by Diabetes

Journal: Current Diabetes Reports

Authors: Roman Starikov, Donald Dudley, Uma M. Reddy

Publisher: Springer US

Login to get access

Abstract

Pregestational diabetes currently complicates 4 % of pregnancies, while gestational diabetes complicates approximately 8 % of pregnancies. Increased risk of stillbirth in diabetic pregnancies has been a well-known and recognized complication for decades. While stillbirth rates for diabetic pregnancies have decreased due to screening, treatment, and antenatal surveillance of these patients, about 4 % of all stillbirths remain attributable to diabetes, and diabetic pregnancies continue to be at increased risk for perinatal mortality. The purpose of this article is to review the literature on the epidemiology, pathophysiology, and prevention, as well as future research, of diabetes-associated perinatal mortality.
Literature
1.
Williams J. The clinical significance of glycosuria in pregnancy women. Am J Med Sci. 1909;137:1.CrossRef
2.
Roman AS, Rebarber A, Fox NS, Klauser CK, et al. The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes. J Matern Fetal Neonatal Med. 2011;24:723–7.CrossRefPubMed
3.
Nohr EA, Villamor E, Vaeth M, et al. Mortality in infants of obese mothers: is risk modified by mode of delivery? Acta Obstet Gynecol Scand. 2012;91:363–71.CrossRefPubMed
4.
Chu S, Kim S, Lau J, et al. Maternal obesity and risk of stillbirth: a meta-analysis. Am J Obstet Gynecol. 2007;197:223–8.CrossRefPubMed
5.
Smith GC, Pell JP, et al. Caesarean section and risk of unexplained stillbirth in subsequent pregnancy. Lancet. 2003;362:1779–84.CrossRefPubMed
6.
Gray R, Quigley M, Hockley C, et al. Caesarean delivery and risk of stillbirth in subsequent pregnancy: a retrospective cohort study in an English population. BJOG. 2007;114:264–70.CrossRefPubMed
7.
Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol. 2006;195:764–70.CrossRefPubMed
8.
Canterino JC, Ananth CV, Smulian J, et al. Maternal age and risk of fetal death in singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal Med. 2004;15:193–7.CrossRefPubMed
9.
Bahtiyar MO, Funai EF, Rosenberg V, et al. Stillbirth at term in women of advanced maternal age in the United States: when could the antenatal testing be initiated? Am J Perinatol. 2008;25:301–4.CrossRefPubMed
10.•
Frey HA, Odibo AO, Dicke JM, et al. Stillbirth risk among fetuses with ultrasound-detected isolated congenital anomalies. Obstet Gynecol 2014 Jun 4. [Epub ahead of print]. Excellent study that compares stillbirth risks in fetuses with and without ultrasound diagnosed congenital abnormalities.
11.
Pauli RM, Reiser CA, Lebovitz RM, Kirkpatrick SJ. Wisconsin Stillbirth Service Program: I. Establishment and assessment of a community-based program for etiologic investigation of intrauterine deaths. Am J Med Genet. 1994;50:116–34.CrossRefPubMed
12.
Laury A, Sanchez-Lara PA, Pepkowitz S, et al. A study of 534 fetal pathology cases from prenatal diagnosis referrals analyzed from 1989 through 2000. Am J Med Genet A. 2007;143A:3107–20.CrossRefPubMed
13.
Korteweg FJ, Bouman K, Erwich JJ, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstet Gynecol. 2008;111:865–74.CrossRefPubMed
14.•
Trudell AS, Cahill AG, Tuuli MG, et al. Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses. Am J Obstet Gynecol. 2013;208:376. This is more recent study confirming previous studies that small for age fetuses are at increased risk for stillbirth.CrossRefPubMed
15.
Clausson B, Gardosi J, Francis A, et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG. 2001;108:830–4.PubMed
16.
Ego A, Subtil D, Grange G, et al. Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. Am J Obstet Gynecol. 2006;194:1042–9.CrossRefPubMed
17.
Standards of medical care in diabetes--2011. American Diabetes Association. Diabetes Care. 2011;34(0suppl 1):S11–61.
18.
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Int Assoc Diabetes Pregnancy Study Groups Consensus Panel Diabetes Care. 2010;33:676–82.
19.
Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 122:406–16.
20.
www.​cdc.​gov accessed on 6/14/14.
21.
Lauenborg J, Mathiesen E, Oveson P, et al. Audit of stillbirth in women with pregestational type 1 diabetes. Diabetes Care. 2003;26:1385–9.CrossRefPubMed
22.
Eidem I, Vangen S, Hanssen KF, et al. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes. Diabetologia. 2011;54:2771–8.CrossRefPubMed
23.
Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies. Diabetes Care. 2009;32:2005–9.CrossRefPubMedCentralPubMed
24.
Jensen D, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies. Diabetes Care. 2004;27:2819–23.CrossRefPubMed
25.
Dos Satos SI, Higgins C, Swerdlow AJ, et al. Birthweight and other pregnancy outcomes in a cohort of women with pregestational insulin-treated diabetes mellitus, Scotland, 1979-1995. Diabet Med. 2005;22:440–7.CrossRef
26.
Penney G, Mair G, Pearson DWM. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG. 2003;110:315–8.CrossRefPubMed
27.
Casson IF, Clarke CA, Howard CV, et al. Outcomes in pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br Med J. 1997;315:275–8.CrossRef
28.
Cundy T, Gamble G, Townende K, et al. Perinatal mortality in type 2 diabetes mellitus. Diabet Med. 2000;17:33–9.CrossRefPubMed
29.
Clausen TD, Matiesen E, Ekbom P, et al. Poor pregnancy outcome in women with type 1. Diabet Care. 2005;28:323–8.CrossRef
30.
de Valk HW, van Nieuwaal NH, Visser GH. Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis form the Netherlands. Rev Diabet Stud. 2006;3:134–42.CrossRefPubMedCentralPubMed
31.
Dunne F, Brydon P, Smith K, et al. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003;20:734–8.CrossRefPubMed
32.
Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177.CrossRefPubMedCentralPubMed
33.
Hawthorne G, Robson S, Ryall EA, et al. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ. 1997;315:279–81.CrossRefPubMedCentralPubMed
34.
Boulot P, Chabbert-Buffet N, d’Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 2003;26:2990–3.CrossRefPubMed
35.
Balsells M, Garcia-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 versus 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94:4284–91.CrossRefPubMed
36.
O’Sullivan JB, Charles D, Mahan CM, et al. Gestation diabetes and perinatal mortality rate. Am J Obstet Gynecol. 1973;116:901–4.PubMed
37.
White BM, Beischer NA. Perinatal mortality in the infants of diabetic women. Aust N Z J Obstet Gynaecol. 1996;36:239–47.CrossRef
38.
Aberg A, Rydhstrom H, Kallen B, et al. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand. 1997;76:212–7.CrossRefPubMed
39.
Wood SL, Jick H, Sauve R. The risk of stillbirth in pregnancies before and after the onset of diabetes. Diabet Med. 2003;20:703–7.CrossRefPubMed
40.
Beisher NA, Wein P, Sheedy MT, et al. Identification and treatment of women with hyperglycemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gyneecol. 1996;36:239–47.CrossRef
41.
Lapolla A, Dalfra MG, Bonomo M, et al. Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol. 2009;145:149–53.CrossRefPubMed
42.
Langer O, Yogev Y, Most O, et al. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.CrossRefPubMed
43.
Langdon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.CrossRef
44.
Mondestin MAJ, Ananth CV, et al. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol. 2002;187:922–6.CrossRefPubMed
45.
Desoye F, Kaufman P. The human placenta in diabetes. In Parta M, Matschinsky FM (eds.) Diabetology of pregnancy. Basel: Karger 2006; 94-109.
46.
Hiden U, Glitzner E, Hartmann M, et al. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat. 2009;215:60–8.CrossRefPubMedCentralPubMed
47.•
Reece EA. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep. 2012;12:24–32. Excellent summary of pathogenesis and congenital abnormalities in pregnancies complicated by gestational diabetes.CrossRefPubMed
48.••
The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirth. JAMA. 2011;306:2459–68. This is a landmark paper that summarizes utility and each test after diagnosis of stillbirth.CrossRef
49.
Scheimberg I. The genetic autopsy. Curr Opin Pediatr. 2013;25:659–65.CrossRefPubMed
50.
Dudley DJ. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin N Am. 2007;34:293–307.CrossRef
51.
Bradley RJ, Brudenell JM, Nicolaides KH. Fetal acidosis and hyperlacticaemenia diagnose by cordocentesis in pregnancies complicated by diabetes mellitus. Diabet Med. 1991;8:464–8.CrossRefPubMed
52.
Salvesen DR, Brudenell JM, Nicolaides KH. Prediction and fetal acidaemia in pregnancies complicated by maternal diabetes mellitus by biophysical profile scoring and fetal heart rate monitoring. BJOG. 1993;100:227–33.CrossRef
53.
Datta S, Jr Brown WU. Acid-base status in diabetic mothers and their infants following general or spinal anesthesia for cesarean section. Anesthesiology. 1977;47:272–6.CrossRefPubMed
54.
Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin dependent diabetes mellitus. Obstet Gynecol. 1995;85:417–22.CrossRefPubMed
55.
Rosenn BM, Miodovnik M. Glycemic control in diabetic pregnancy: is tighter always better? J Matern Fetal Med. 2000;9:29–34.CrossRefPubMed
56.
Chandler KD, Leury BJ, Bird AR, et al. Effects of undernutrition and exercise during late pregnancy on uterine, fetal and uteroplacental metabolism in the ewe. Br J Nutr. 1985;53:625–35.CrossRefPubMed
57.
Veille JC, Sivakoff M, Hanson R, et al. Interventricular septal thickness in fetuses of diabetic mothers. Obtet Gynecol. 1992;79:51–4.
58.
Russell NE, Holloway P, Quinn S, et al. Cardiomyopathy and cardiomegaly in stillborn of infants of diabetic mothers. Pediatr Dev Pathol. 2008;11:10–1.CrossRefPubMed
59.
Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004;25:137–40.CrossRefPubMed
60.
Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199:237. e1-9.CrossRefPubMed
61.
Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1–9.PubMed
62.
Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart. 2003;89:1217–20.CrossRefPubMedCentralPubMed
63.
Piper JM, Lander O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol. 1993;168:783–6.CrossRefPubMed
64.
Piper JM, Xenakis EMJ, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern-Fetal Med. 1998;7:148–53.CrossRefPubMed
65.
Diabetes care and research in Europe: the Saint Vincent declaration. Diabetic Med 1990;7:360.
66.
Hadden DR, Alexander A, McCance DR, et al. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabet Med. 2001;18:546–53.CrossRefPubMed
67.
Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38:139–45.CrossRefPubMed
68.
Friedman AM, Cleary KL. Prediction and prevention of ischemic placental disease. Semin Perinatol. 2014;38:139–45.CrossRef
69.
Poston L, Briley AL, Seed PT, et al. Vitamins and pre-eclampsia trial C. Vitamins C and E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet. 2006;367:1145–54.CrossRefPubMed
70.
Villar J, Purvar M, Merialdi M, et al. World Health Organisation multicentre randomized trial of supplementation with vitamins C and E among pregnant women at risk for preeclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116:780–8.CrossRefPubMed
71.
Rumbold AR, Crowther CA, Haslam RR, et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006;354:1796–806.CrossRefPubMed
72.
Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complication of pregnancy associated hypertension. N Engl J Med. 2010;362:1282–91.CrossRefPubMedCentralPubMed
73.
Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using Low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41:491–9.CrossRefPubMed
74.
Henderson JT, Whitlock EP, O’Connor E, et al. Aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Inter Med. 2014;160:695–705.CrossRef
75.
Miller E, Hare JW, Cloherty JP, Dunn PJ, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital abnormalities in infants of diabetic mothers. N Engl J Med. 1981;304:1331–4.CrossRefPubMed
76.
Starikov R, Bohrer J, Goh W, et al. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol. 2013;34:1716–22.CrossRefPubMed
77.
Ylinen K, Aula P, Stenman UH, et al. Risk of minor and major malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J. 1984;289:345–6.CrossRef
78.
Nielsen GL, Sorenson PH, Neilsen PH, et al. Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol. 1997;34:217–22.CrossRefPubMed
79.
Starikov R, Inman K, Chien EK, et al. Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients? J Diabetes Complications. 2014;28:203–7.CrossRefPubMed
80.
Pregestational diabetes mellitus. Practice Bulletin No. 60. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:675-85.
81.
Antepartum fetal surveillance. Practice Bulletin No 145. American College of Obstetricians and Gynecologist. Obstet Gynecol 2014; 124:182-192
82.
Fetal macrosomia. Practice Bulletin No. 22. American College of Obstetricians and Gynecologists. Obstet Gynecol 2000.
83.
Deter RL, Hadlock FP. Use of ultrasound in the detection of macrosomia: a review. J Clin Ultrasound. 1985;13:519–24.CrossRefPubMed
84.
Rossavik IK, Joslin GL. Macrosomatia and ultrasonography: what is the problem? South Med J. 1993;86:1129–32.CrossRefPubMed
85.
Sandmire HF. Whither ultrasonic prediction of fetal macrosomia? Obstet Gynecol. 1993;82:860–2.PubMed
86.
Spong CY, Mercer BM, D’Alton M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol. 2011;118:323–33.CrossRefPubMedCentralPubMed
87.•
Medically indicated late-preterm and early term deliveries. Committee Opinion No 560 American College of Obstetricians and Gynecologists. Obtet Gynecol 2013;121:908-10. This is very important document that summarizes timing of delivery for mothers with medical complications.
88.••
Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014 [Epub]. Executive summary of diagnosis and treatment of fetal cardiac diseases.
89.
American Institute of Ultrasound in Medicine. AIUM practice guidelines for the performance of fetal echocardiography. J Ultrasound Med. 2013;32:1067–82.CrossRef
90.
Yogev Y, Hod M. Use of new technologies for monitoring and treating diabetes in pregnancy. Obstet Gynecol Clin N Am. 2007;34:241–53.CrossRef

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »

Image Credits